Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritis

Introduction: Osteo-arthritis (OA) involves joint degradation and usually pain; with mechanisms poorly understood and few treatment options. There is evidence that the transient receptor potential canonical 5 (TRPC5) mRNA expression is reduced in OA patients’ synovia. Here we examine the profile of...

Full description

Bibliographic Details
Main Authors: João de Sousa Valente, Khadija M. Alawi, Patrik Keringer, Sabah Bharde, Faseeha Ayaz, Nurjahan Saleque, Xenia Kodji, Dibesh Thapa, Fulye Argunhan, Susan D. Brain
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Osteoarthritis and Cartilage Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2665913120301199
id doaj-2c54f1ea129e4e75adabb9d90137596c
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author João de Sousa Valente
Khadija M. Alawi
Patrik Keringer
Sabah Bharde
Faseeha Ayaz
Nurjahan Saleque
Xenia Kodji
Dibesh Thapa
Fulye Argunhan
Susan D. Brain
spellingShingle João de Sousa Valente
Khadija M. Alawi
Patrik Keringer
Sabah Bharde
Faseeha Ayaz
Nurjahan Saleque
Xenia Kodji
Dibesh Thapa
Fulye Argunhan
Susan D. Brain
Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritis
Osteoarthritis and Cartilage Open
TRPC5
Osteoarthritis
Inflammation
Synovitis
author_facet João de Sousa Valente
Khadija M. Alawi
Patrik Keringer
Sabah Bharde
Faseeha Ayaz
Nurjahan Saleque
Xenia Kodji
Dibesh Thapa
Fulye Argunhan
Susan D. Brain
author_sort João de Sousa Valente
title Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritis
title_short Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritis
title_full Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritis
title_fullStr Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritis
title_full_unstemmed Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritis
title_sort examining the role of transient receptor potential canonical 5 (trpc5) in osteoarthritis
publisher Elsevier
series Osteoarthritis and Cartilage Open
issn 2665-9131
publishDate 2020-12-01
description Introduction: Osteo-arthritis (OA) involves joint degradation and usually pain; with mechanisms poorly understood and few treatment options. There is evidence that the transient receptor potential canonical 5 (TRPC5) mRNA expression is reduced in OA patients’ synovia. Here we examine the profile of TRPC5 in DRG and involvement in murine models of OA. Design: TRPC5 KO mice were subjected to partial meniscectomy (PMNX) or injected with monoiodoacetate (MIA) and pain-related behaviours were determined. Knee joint pathological scores were analysed and gene expression changes in ipsilateral synovium and dorsal root ganglia (DRG) determined. c-Fos protein expression in the ipsilateral dorsal horn of the spinal cord was quantified. Results: TRPC5 KO mice developed a discrete enhanced pain-related phenotype. In the MIA model, the pain-related phenotype correlated with c-Fos expression in the dorsal horn and increased expression of nerve injury markers ATF3, CSF1 and galanin in the ipsilateral DRG. There were negligible differences in the joint pathology between WT and TRPC5 KO mice, however detailed gene expression analysis determined increased expression of the mast cell marker CD117 as well as extracellular matrix remodelling proteinases MMP2, MMP13 and ADAMTS4 in MIA-treated TRPC5 KO mice. TRPC5 expression was defined to sensory subpopulations in DRG. Conclusions: Deletion of TRPC5 receptor signalling is associated with exacerbation of pain-like behaviour in OA which correlates with increased expression of enzymes involved in extracellular remodelling, inflammatory cells in the synovium and increased neuronal activation and injury in DRG. Together, these results identify a modulating role for TRPC5 in OA-induced pain-like behaviours.
topic TRPC5
Osteoarthritis
Inflammation
Synovitis
url http://www.sciencedirect.com/science/article/pii/S2665913120301199
work_keys_str_mv AT joaodesousavalente examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT khadijamalawi examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT patrikkeringer examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT sabahbharde examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT faseehaayaz examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT nurjahansaleque examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT xeniakodji examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT dibeshthapa examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT fulyeargunhan examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
AT susandbrain examiningtheroleoftransientreceptorpotentialcanonical5trpc5inosteoarthritis
_version_ 1716843565588414464
spelling doaj-2c54f1ea129e4e75adabb9d90137596c2021-10-05T04:20:39ZengElsevierOsteoarthritis and Cartilage Open2665-91312020-12-0124100119Examining the role of transient receptor potential canonical 5 (TRPC5) in osteoarthritisJoão de Sousa Valente0Khadija M. Alawi1Patrik Keringer2Sabah Bharde3Faseeha Ayaz4Nurjahan Saleque5Xenia Kodji6Dibesh Thapa7Fulye Argunhan8Susan D. Brain9Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKSection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKDepartment of Thermophysiology, Institute for Translational Medicine, Medical School, University of Pecs, 12 Szigeti Str., Pecs, H7624, HungarySection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKSection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKSection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKSection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKSection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKSection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UKSection of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Research Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UK; Corresponding author. Vascular Biology and Inflammation Section, Cardiovascular School of Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UK.Introduction: Osteo-arthritis (OA) involves joint degradation and usually pain; with mechanisms poorly understood and few treatment options. There is evidence that the transient receptor potential canonical 5 (TRPC5) mRNA expression is reduced in OA patients’ synovia. Here we examine the profile of TRPC5 in DRG and involvement in murine models of OA. Design: TRPC5 KO mice were subjected to partial meniscectomy (PMNX) or injected with monoiodoacetate (MIA) and pain-related behaviours were determined. Knee joint pathological scores were analysed and gene expression changes in ipsilateral synovium and dorsal root ganglia (DRG) determined. c-Fos protein expression in the ipsilateral dorsal horn of the spinal cord was quantified. Results: TRPC5 KO mice developed a discrete enhanced pain-related phenotype. In the MIA model, the pain-related phenotype correlated with c-Fos expression in the dorsal horn and increased expression of nerve injury markers ATF3, CSF1 and galanin in the ipsilateral DRG. There were negligible differences in the joint pathology between WT and TRPC5 KO mice, however detailed gene expression analysis determined increased expression of the mast cell marker CD117 as well as extracellular matrix remodelling proteinases MMP2, MMP13 and ADAMTS4 in MIA-treated TRPC5 KO mice. TRPC5 expression was defined to sensory subpopulations in DRG. Conclusions: Deletion of TRPC5 receptor signalling is associated with exacerbation of pain-like behaviour in OA which correlates with increased expression of enzymes involved in extracellular remodelling, inflammatory cells in the synovium and increased neuronal activation and injury in DRG. Together, these results identify a modulating role for TRPC5 in OA-induced pain-like behaviours.http://www.sciencedirect.com/science/article/pii/S2665913120301199TRPC5OsteoarthritisInflammationSynovitis